Materials & Packaging

Request for TOC Request for Sample
BUY NOW

Global Primary Pharmaceutical Packaging Market – Industry Trends and Forecast to 2030

Materials & Packaging | Upcoming Report | Oct 2023 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60

Report Description

Global Primary Pharmaceutical Packaging Market, By Type (Plastic Bottles, Blister Packs, Labels and Accessories, Caps and Closures, Medical Specialty Bags, Pre-Filled Syringes, Temperature-Controlled Packaging, Pouches and Strip Packs, Ampoules, Vials, Pre-Filled Inhalers, Medication Tubes, Jars and Canisters, Cartridges, Others), Material (Plastics and Polymers, Paper & Paperboards, Glass, Metals, Others), Drug Delivery (Oral Drug Delivery Packaging, Pulmonary Drug Delivery Packaging, Transdermal Drug Delivery Packaging, Injectable Packaging, Topical Drug Delivery Packaging, Nasal Drug Delivery Packaging, Ocular Drug Delivery Packaging, Iv Drugs Delivery Packaging, Other Drugs Delivery Packaging) - Industry Trends and Forecast to 2030.

Get Exclusive Sample Copy of this Report Here

Primary Pharmaceutical Packaging Market Analysis and Size

The rise in pharmaceutical industry across the globe acts as one of the major factors driving the growth of global primary pharmaceutical packaging market. The surge in number of advanced manufacturing processes to develop sustainable and eco-friendly packaging solutions, and adoption of serialized tracking and tracing of drugs accelerate the market growth. In addition, growth in awareness, breakthrough in new technologies, increase in knowledge about preventive healthcare, change in consumer preference and growing use of the smart packaging for patient engagement and identification positively affect the global primary pharmaceutical packaging market

Data Bridge Market Research analyses that the global primary pharmaceutical packaging market which was USD 91,612.15 million in 2022, is expected to reach USD 142,143.95 million by 2030, growing at a CAGR of 5.8% during the forecast period of 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in (depth expert analysis, geographically represented company (wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Primary Pharmaceutical Packaging Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volume in Units, Price in USD

Segments Covered

Type (Plastic Bottles, Blister Packs, Labels and Accessories, Caps and Closures, Medical Specialty Bags, Pre-Filled Syringes, Temperature-Controlled Packaging, Pouches and Strip Packs, Ampoules, Vials, Pre-Filled Inhalers, Medication Tubes, Jars and Canisters, Cartridges, Others), Material (Plastics and Polymers, Paper and Paperboards, Glass, Metals, Others), Drug Delivery (Oral Drug Delivery Packaging, Pulmonary Drug Delivery Packaging, Transdermal Drug Delivery Packaging, Injectable Packaging, Topical Drug Delivery Packaging, Nasal Drug Delivery Packaging, Ocular Drug Delivery Packaging, Iv Drugs Delivery Packaging, Other Drugs Delivery Packaging)

Countries Covered

U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Rest of Middle East and Africa

Market Players Covered

3M (U.S.), BD (U.S.), CCL Industries  (Canada), McKesson Corporation (U.S.), WestRock Company (U.S.), West Pharmaceutical Services Inc. (U.S.), Klöckner Pentaplast (U.S.), SCHOTT AG (Germany), Amcor plc (Switzerland), Berry Global Inc. (U.S.), FlexiTuff Ventures International Ltd. (India), International Paper (U.S.), Stevanato Group (Italy), Origin Pharma Packaging (U.K.), Mondi (U.K.), Lonza (Switzerland), Robert Bosch GmbH (Germany), DuPont (U.S.), Thermo Fisher Scientific (U.S.), Boston Scientific (U.S.), AptarGroup Inc. (U.S.), and Gerresheimer AG (Germany)

Market Opportunities

  • Growth in pharmaceutical industry
  • Stringent regulatory requirement

Market Definition

Primary pharmaceutical packaging refers to the packaging that directly contains the pharmaceutical product, such as tablets, capsules, vials, syringes, or ampoules. It is the first layer of packaging that comes into direct contact with the medication and is designed to protect the product from external factors, maintain its integrity, and ensure its safety and efficacy throughout its shelf life.

Global Primary Pharmaceutical Packaging Market Dynamics

Drivers

  • Growth in Pharmaceutical Industry

The pharmaceutical industry is expanding globally due to increasing healthcare needs, population growth, and the prevalence of chronic diseases. This growth leads to higher demand for primary pharmaceutical packaging materials and solutions.

  • Stringent Regulatory Requirement

Regulatory agencies, such as the FDA (Food and Drug Administration) in the U.S. and the EMA (European Medicines Agency) in Europe, have strict packaging and labelling regulations to ensure product safety and traceability. Compliance with these regulations drives the demand for specialized packaging solutions.

Opportunities

  • Globalization of the Pharmaceutical Supply Chain

Pharmaceutical supply chains are becoming more global, increasing the need for packaging materials that can withstand international shipping and maintain product integrity. Moreover, expanding healthcare access in emerging markets drives the demand for pharmaceuticals, resulting in increased requirements for primary packaging materials and solutions.

  • Rising Investments for Research and Development

Ongoing research and development efforts in the pharmaceutical packaging industry lead to the creation of innovative packaging materials and designs that meet evolving needs. In addition, advances in drug delivery technologies, such as prefilled syringes, auto-injectors, and blister packs, require specialized primary packaging materials and designs to facilitate accurate dosing and ease of use.

Restraints/Challenges

  • Packaging Waste and Sustainability Issues

Balancing the need for sustainability with regulatory requirements can be challenging. Biodegradable and sustainable packaging materials may not always meet stringent pharmaceutical packaging standards, leading to a trade-off between environmental goals and product safety.

  • Competitive Pricing Pressure

The pharmaceutical industry faces continuous pressure to reduce costs while maintaining high-quality packaging. This cost pressure can limit investments in innovative packaging solutions. Economic fluctuations and recessions can impact pharmaceutical companies' budgets and investments in packaging.

This global primary pharmaceutical packaging market report provides details of new recent developments, trade regulations, import (export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global primary pharmaceutical packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high (level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions. Apart from the standard report, we also offer in (depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Developments

  • In February 2023, Gerresheimer unveiled its latest offering, the Clinical Trial Kit, during the Pharmapack event in Paris. The comprehensive kit includes sterile Gx RTF vials in nest and tub or tray, along with matching closures, catering to pharmaceutical companies engaged in over 3,000 injectable drug programs in pre-clinical and clinical phases. The kit is designed to provide top-tier primary packaging solutions and supportive services
  • In February 2023, Berry Global Healthcare achieved a significant milestone with the introduction of a fully accredited child-resistant (CRC) and tamper-evident (TE) packaging solution tailored for the pharmaceutical and herbal market, catering specifically to syrup and liquid medicines. The comprehensive offering encompasses seven ranges of 28mm neck PET bottles, available in sizes ranging from 20ml to 1,000ml, offering diverse design options to cater to various customer needs.

Global Primary Pharmaceutical Packaging Market Scope

The global primary pharmaceutical packaging market is segmented on the basis of basis of type, material and drug delivery. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.           

Type

  • Plastic Bottles
  • Blister Packs
  • Labels and Accessories
  • Caps and Closures
  • Medical Specialty Bags
  • Pre-Filled Syringes
  • Temperature-Controlled Packaging
  • Pouches and Strip Packs
  • Ampoules
  • Vials
  • Pre-Filled Inhalers
  • Medication Tubes
  • Jars and Canisters
  • Cartridges
  • Others

Material

  • Plastics and Polymers
  • Paper and Paperboards
  • Glass
  • Metals
  • Others

Drug Delivery

  • Oral Drug Delivery Packaging
  • Pulmonary Drug Delivery Packaging
  • Transdermal Drug Delivery Packaging
  • Injectable Packaging
  • Topical Drug Delivery Packaging
  • Nasal Drug Delivery Packaging
  • Ocular Drug Delivery Packaging
  • IV Drugs Delivery Packaging
  • Other Drugs Delivery Packaging

Global Primary Pharmaceutical Packaging Market Regional Analysis/Insights

The global primary pharmaceutical packaging market is analysed and market size insights and trends are provided by basis of type, material and drug delivery as referenced above.

The countries covered in the global primary pharmaceutical packaging market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Rest of Middle East and Africa

North America is expected to dominate the global primary pharmaceutical packaging market due to the presence of key players and strategic developments by the raw material suppliers within the region.

Asia-Pacific is expected to witness fastest-growing region during the forecast period of 2023 to 2030 because of the increase in government initiatives in emerging pharmaceutical in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Primary Pharmaceutical Packaging Market Share Analysis

The global primary pharmaceutical packaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global primary pharmaceutical packaging market.

Some of the major players operating in the global primary pharmaceutical packaging market are:

  • 3M (U.S.)
  • BD (U.S.)
  • CCL Industries  (Canada)
  • McKesson Corporation (U.S.)
  • WestRock Company (U.S.)
  • West Pharmaceutical Services Inc. (U.S.)
  • Klöckner Pentaplast (U.S.)
  • SCHOTT AG (Germany)
  • Amcor plc (Switzerland)
  • Berry Global Inc. (U.S.)
  • FlexiTuff Ventures International Ltd. (India)
  • International Paper (U.S.)
  • Stevanato Group (Italy)
  • Origin Pharma Packaging (U.K.)
  • Mondi (U.K.)
  • Lonza (Switzerland)
  • Robert Bosch GmbH (Germany)
  • DuPont (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Boston Scientific (U.S.)
  • AptarGroup Inc. (U.S.)
  • Gerresheimer AG (Germany)


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19